Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Income from Non-Controlling Interests (2024 - 2025)

Historic Income from Non-Controlling Interests for Coeptis Therapeutics Holdings (COEP) over the last 2 years, with Q3 2025 value amounting to $159360.0.

  • Coeptis Therapeutics Holdings' Income from Non-Controlling Interests rose 6544.51% to $159360.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 227149.56%. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • Coeptis Therapeutics Holdings' Income from Non-Controlling Interests amounted to $159360.0 in Q3 2025, which was up 6544.51% from $799991.0 recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Income from Non-Controlling Interests peaked at $961710.0 during Q4 2024, and registered a low of $96322.0 during Q3 2024.